News & Events
-
BioXtreme has made it to the Reinhold Cohn 2021 startup competition finals!
17/12/2020Click here to read more…
-
BioXtreme strengthens management team with new sales manager
17/12/2020Click here to read more…
-
BioXtreme Announces CE Marking
17/12/2020Click here to read more…
-
BioXtreme announces strategic partnership with Dutch innovation lab Jamzone
17/12/2020Click here to read more…
-
BioXtreme receives ISO-13458 certification
14/12/2020Click here to read more…
-
We are proud to announce that BioXtreme is awarded a R&D grant from the Israel Innovation Authority
01/08/2020Click here to read more…
-
BioXtreme and Heliomare rehabilitation centre will conduct a joint clinical trial research project on deXtreme™ in Heliomare facility in the Netherlands
01/03/2020Click here to read more…
-
BioXtreme is proud to announce that our product, deXtreme™ is FDA registered!
17/01/2020Registration took place at 17/2/2020. BioXtreme’s FDA owner/operator number is 10062549
-
BioXtreme will exhibit in 11th World Congress for Neurorehabilitation
-
BioXtreme will showcase deXteme™ 3.0 in the upcoming European Neuro Convention
